Seven-Year Legal Challenge To Japan’s OTC Online Sales Ban Fails
Executive Summary
Japan’s Supreme Court has delivered a final ruling on a seven year dispute over online sales of non-prescription medicines. The Court has rejected a complaint against the ban on distant selling of OTCs in the most-strictly-regulated category, that of recently switched drugs. Meanwhile, the Japanese government is extending the country’s Self-Medication Tax Deduction System for another five years.
You may also be interested in...
Japan Embarks On Rx-To-OTC Switch Revolution
The Japanese government has approved a raft of measures aimed at expanding the country's consumer health market, including reforms to an Evaluation Committee that has not lived up to its promise of expediting Rx-to-OTC switches.
Asia’s OTC Market Stunted By Regulatory Disharmony
HBW Insight Exclusive: A lack of regulatory harmonization, especially with regards to Rx-to-OTC switch, is holding the Asia-Pacific OTC market back, according to APSMI secretary general, Toshi Tominaga.
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.